These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8393379

  • 1. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR.
    Cancer Res; 1993 Aug 15; 53(16):3712-8. PubMed ID: 8393379
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR.
    Cancer Res; 1994 Aug 01; 54(15):4057-64. PubMed ID: 8033137
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
    Evans SR, Houghton AM, Schumaker L, Brenner RV, Buras RR, Davoodi F, Nauta RJ, Shabahang M.
    J Surg Res; 1996 Feb 15; 61(1):127-33. PubMed ID: 8769954
    [Abstract] [Full Text] [Related]

  • 5. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M, Rech M, Meineke V, Tilgen W, Reichrath J.
    J Steroid Biochem Mol Biol; 2004 May 15; 89-90(1-5):375-9. PubMed ID: 15225804
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS, Puente XS, Alvarez S, Tolivia J, Binderup L, López-Otín C.
    Cancer Res; 1997 Sep 15; 57(18):4091-7. PubMed ID: 9307298
    [Abstract] [Full Text] [Related]

  • 7. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
    Higashimoto Y, Ohata M, Nishio K, Iwamoto Y, Fujimoto H, Uetani K, Suruda T, Nakamura Y, Funasako M, Saijo N.
    Anticancer Res; 1996 Sep 15; 16(5A):2653-9. PubMed ID: 8917365
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR, Schwartz AM, Shchepotin EI, Uskokovic M, Shchepotin IB.
    Clin Cancer Res; 1998 Nov 15; 4(11):2869-76. PubMed ID: 9829754
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation.
    Kondoh N, Schweinfest CW, Henderson KW, Papas TS.
    Cancer Res; 1992 Feb 15; 52(4):791-6. PubMed ID: 1339304
    [Abstract] [Full Text] [Related]

  • 10. 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.
    Franceschi RT, James WM, Zerlauth G.
    J Cell Physiol; 1985 Jun 15; 123(3):401-9. PubMed ID: 2985632
    [Abstract] [Full Text] [Related]

  • 11. The role of vitamin D3 receptor mRNA in the proliferation of hepatocellular carcinoma.
    Miyaguchi S, Watanabe T.
    Hepatogastroenterology; 2000 Jun 15; 47(32):468-72. PubMed ID: 10791215
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer.
    Cross HS, Bajna E, Bises G, Genser D, Kállay E, Pötzi R, Wenzl E, Wrba F, Roka R, Peterlik M.
    Anticancer Res; 1996 Jun 15; 16(4B):2333-7. PubMed ID: 8694565
    [Abstract] [Full Text] [Related]

  • 13. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Jun 15; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of the content of 1,25-dihydroxyvitamin D3 receptors in digestive mucosa and adenocarcinoma].
    Meggouh F, Lointier P, Pezet D, Saez S.
    Bull Cancer; 1990 Jun 15; 77(3):205-12. PubMed ID: 2160306
    [Abstract] [Full Text] [Related]

  • 15. [Correlation between the concentration of 1,25 alpha dihydroxyvitamin D3 receptors and growth inhibition, and differentiation of human osteosarcoma cells induced by vitamin D3].
    Tokuumi Y.
    Nihon Seikeigeka Gakkai Zasshi; 1995 Apr 15; 69(4):181-90. PubMed ID: 7782656
    [Abstract] [Full Text] [Related]

  • 16. 1 alpha,25-Dihydroxyvitamin D3 induces anchorage-independent growth and c-Ki-ras expression of BALB/3T3 and NIH/3T3 cells.
    Huh N, Satoh M, Nose K, Abe E, Suda T, Rajewsky MF, Kuroki T.
    Jpn J Cancer Res; 1987 Feb 15; 78(2):99-102. PubMed ID: 3030988
    [Abstract] [Full Text] [Related]

  • 17. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
    Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moore GE, Moseley JM, Martin TJ.
    Cancer Res; 1982 Mar 15; 42(3):1116-9. PubMed ID: 6277475
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth.
    Tong WM, Hofer H, Ellinger A, Peterlik M, Cross HS.
    Oncol Res; 1999 Mar 15; 11(2):77-84. PubMed ID: 10489163
    [Abstract] [Full Text] [Related]

  • 19. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.
    Lointier P, Wargovich MJ, Saez S, Levin B, Wildrick DM, Boman BM.
    Anticancer Res; 1987 Mar 15; 7(4B):817-21. PubMed ID: 2823686
    [Abstract] [Full Text] [Related]

  • 20. Specific receptors for 1,25-dihydroxyvitamin D3 (1,25-DR) and human colorectal carcinogenesis.
    Lointier P, Meggouh F, Pezet D, Dapoigny M, Dieng PN, Saez S, Chipponi J.
    Anticancer Res; 1989 Mar 15; 9(6):1921-4. PubMed ID: 2560626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.